Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
J Immunother Cancer
; 11(2)2023 02.
Article
in En
| MEDLINE
| ID: mdl-36822667
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
B7-H1 Antigen
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2023
Document type:
Article
Affiliation country:
United States